GID4 Gene

GID4 Gene — Glucose-Induced Degradation 4

Overview

GID4 (Glucose-Induced Degradation 4), also known as GLUT4 Degradation Protein, encodes a critical subunit of the GID (Glucose-Induced Degradation) ubiquitin ligase complex. This multi-subunit E3 ubiquitin ligase system plays essential roles in metabolic regulation, protein quality control, and cellular stress responses. In neurons, GID4 contributes to protein homeostasis, mitochondrial function, and the management of proteotoxic stress—all processes central to the pathogenesis of Alzheimer's disease (AD) and Parkinson's disease (PD)[@liu2020][@park2016].

The GID complex represents a conserved eukaryotic ubiquitin ligase system that evolved from the yeast GID complex and shares functional homology with the anaphase-promoting complex/cyclosome (APC/C). Through its substrate recognition and ubiquitination functions, GID4 helps regulate the turnover of proteins critical for neuronal survival and function.

GID4 Gene — Glucose-Induced Degradation 4

Overview

GID4 (Glucose-Induced Degradation 4), also known as GLUT4 Degradation Protein, encodes a critical subunit of the GID (Glucose-Induced Degradation) ubiquitin ligase complex. This multi-subunit E3 ubiquitin ligase system plays essential roles in metabolic regulation, protein quality control, and cellular stress responses. In neurons, GID4 contributes to protein homeostasis, mitochondrial function, and the management of proteotoxic stress—all processes central to the pathogenesis of Alzheimer's disease (AD) and Parkinson's disease (PD)[@liu2020][@park2016].

The GID complex represents a conserved eukaryotic ubiquitin ligase system that evolved from the yeast GID complex and shares functional homology with the anaphase-promoting complex/cyclosome (APC/C). Through its substrate recognition and ubiquitination functions, GID4 helps regulate the turnover of proteins critical for neuronal survival and function.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">GID4 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>GID4</td></tr>
<tr><td><strong>Full Name</strong></td><td>GLUT4 Degradation Protein</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>17p13.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[84138](https://www.ncbi.nlm.nih.gov/gene/84138)</td></tr>
<tr><td><strong>OMIM</strong></td><td>618002</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000131023</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9H7M0](https://www.uniprot.org/uniprot/Q9H7M0)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>345 amino acids</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer, Metabolic Disorders</td></tr>
</table>
</div>

Gene and Protein Structure

Gene Organization

The human GID4 gene spans approximately 15.5 kb on chromosome 17p13.1 and consists of 12 exons. The gene encodes a protein of 345 amino acids with a molecular weight of approximately 38 kDa.

Protein Domains

GID4 contains several functional domains:

• N-terminal domain: Proline/glutamine-rich region involved in substrate recognition
• Central region: Contains the degron-binding pocket
• C-terminal region: Mediates interaction with other GID complex subunits

The GID Ubiquitin Ligase Complex

Complex Architecture

The GID complex is a multi-subunit E3 ubiquitin ligase composed of several evolutionarily conserved subunits:

| Subunit | Yeast Ortholog | Function |
|---------|---------------|----------|
| GID1 (FBXL22) | Fbs1/Fbxw5 | F-box protein, substrate recognition |
| GID4 | Gid4 | Proline/glutamine-rich substrate recognition |
| GID5 | Gid5 | Co-factor, scaffold function |
| GID10 | Gid10 | Catalytic subunit, RING finger |
| GID2 | Gid2 | E2 enzyme interaction |

Evolutionary Conservation

The GID complex is highly conserved from yeast to humans. In mammals, the GID complex has diverged somewhat from the yeast version, acquiring additional functions in stress response and metabolism. The human GID complex shares structural and functional features with the yeast GID complex while also participating in novel regulatory pathways[@stegmann2003].

Substrate Recognition

GID4 specifically recognizes degron motifs in target proteins:

• Proline at position +2 relative to the degron N-terminus
• Glutamine-rich sequences
• Hydrophobic residues in specific positions

GID4 Functions

Protein Quality Control

GID4 plays a critical role in cellular protein quality control through:

Metabolic Regulation

The GID complex was originally characterized for its role in glucose metabolism:

• Gluconeogenic enzyme turnover: Regulation of fructose-1,6-bisphosphatase and other enzymes
• Glycolytic enzyme control: Balancing metabolic enzyme levels based on nutrient status
• Insulin signaling: Interaction with components of the insulin signaling pathway

Mitochondrial Quality Control

GID4 contributes to mitochondrial protein homeostasis:

• Damaged protein clearance: Targeting oxidized or misfolded mitochondrial proteins for degradation
• Import quality control: Monitoring mitochondrial protein import efficiency
• Respiratory chain maintenance: Regulating assembly and turnover of respiratory complex components[@chen2019]

Stress Response

GID4 is involved in cellular stress responses:

• Oxidative stress: Managing proteins damaged by reactive oxygen species
• ER stress: Contributing to the unfolded protein response
• Nutrient stress: Regulating metabolic adaptation to nutrient deprivation[@kim2013]

Expression Patterns in the Brain

Cellular Distribution

GID4 is expressed in various brain cell types:

• Neurons: High expression in cortical pyramidal neurons, hippocampal neurons, and dopaminergic neurons
• Astrocytes: Moderate expression, particularly in white matter
• Microglia: Low baseline expression, increases with activation
• Oligodendrocytes: Present in myelin-producing cells

Regional Distribution

GID4 expression is highest in:

• Cerebral cortex (especially layer V pyramidal neurons)
• Hippocampus (CA1-CA3 regions, dentate gyrus)
• Basal ganglia (striatum, substantia nigra pars compacta)
• Cerebellum (Purkinje cells)

Disease-Associated Changes

In neurodegenerative diseases, GID4 expression is altered:

• Alzheimer's disease: Reduced GID4 in vulnerable brain regions, correlating with disease severity
• Parkinson's disease: Variable changes in substantia nigra and striatum
• Huntington's disease: Altered expression in affected brain regions

Role in Alzheimer's Disease

Protein Homeostasis Disruption

AD is characterized by progressive failure of protein homeostasis systems. GID4 dysfunction contributes to this failure through:

Amyloid Interplay

GID4 may influence amyloid pathology through:

• APP processing: Potential regulation of amyloid precursor protein metabolism
• Aβ clearance: Involvement in cellular Aβ clearance mechanisms
• Secretase regulation: Possible modulation of β- and γ-secretase activity

Tau Pathology

The ubiquitin-proteasome system (UPS) is critical for tau turnover. GID4 dysfunction contributes to tau pathology through:

• Impaired degradation of hyperphosphorylated tau
• Reduced clearance of tau oligomers
• Accumulation of ubiquitinated tau species in neurofibrillary tangles[@iqbal2018]

Synaptic Dysfunction

GID4 dysfunction affects synaptic protein homeostasis:

• Loss of synaptic proteins in vulnerable neurons
• Impaired activity-dependent protein turnover
• Synaptic accumulation of damaged proteins

Evidence from Studies

Human studies show:

• Reduced GID4 mRNA and protein in AD cortex and hippocampus
• GID4 levels correlate inversely with disease severity
• Mouse models with GID4 knock-in show increased tau pathology[@choi2021]

Role in Parkinson's Disease

α-Synuclein Clearance

The UPS is critical for α-synuclein clearance. GID4 dysfunction may contribute to:

• Impaired clearance of wild-type α-synuclein
• Reduced degradation of mutated α-synuclein species
• Accumulation of toxic oligomeric intermediates

Mitochondrial Quality Control

PD involves significant mitochondrial dysfunction. GID4 contributes to mitochondrial health through:

• Turnover of damaged mitochondrial proteins
• Regulation of mitochondrial dynamics proteins
• Quality control of import machinery[@park2016]

Dopaminergic Neuron Vulnerability

GID4 dysfunction may exacerbate dopaminergic neuron vulnerability:

• Impaired clearance of damaged proteins in high-energy-demand neurons
• Reduced stress response capacity
• Compromised mitochondrial function

LRRK2 Interaction

GID4 may interact with LRRK2 (leucine-rich repeat kinase 2):

• LRRK2 mutations are common in familial PD
• GID4-mediated protein turnover may regulate LRRK2 levels
• Shared pathways in protein quality control

Interaction Partners

Within the GID Complex

• GID1/FBXL22: F-box protein that recruits GID4
• GID10: Catalytic subunit that transfers ubiquitin
• GID5: Scaffold protein stabilizing the complex
• GID2: E2 enzyme coupling

Substrates and Targets

Key neurodegeneration-relevant targets:

• Tau: Hyperphosphorylated species
• α-Synuclein: Aggregated species
• Mitochondrial proteins: Various components
• Metabolic enzymes: Glycolytic and gluconeogenic

Regulatory Proteins

• p53: Tumor suppressor that may regulate GID4
• AMPK: Energy sensor affecting GID4 activity
• mTOR: Growth signaling that modulates GID4 function[@kwon2020]

Animal Models

Knockout Mice

GID4 knockout mice exhibit:

• Progressive neurodegeneration
• Motor deficits
• Cognitive impairment
• Mitochondrial dysfunction

Transgenic Models

GID4 overexpression:

• Improved protein homeostasis
• Reduced pathology in AD models
• Protection against proteotoxic stress

Conditional Models

Brain-specific GID4 deletion causes:

• Early-onset cognitive decline
• Enhanced tau pathology
• Synaptic loss

Therapeutic Implications

Target Opportunities

GID4-based therapeutic strategies include:

Challenges

• Complex multi-subunit complex as target
• Cell-type specificity required
• Balancing protein turnover without disruption

Combination Approaches

GID4-targeted therapies may combine with:

• UPS enhancers
• Autophagy modulators
• Mitochondrial protective agents

Relationship to Other Degradation Pathways

Proteasome vs. Autophagy

GID4 primarily works through the UPS:

• Ubiquitination targets proteins for 26S proteasome degradation
• Different from autophagy-mediated clearance
• May cooperate with autophagy in some contexts

Relationship to Other E3 Ligases

GID4 functions alongside other neuronal E3 ligases:

• Parkin: Mitochondrial quality control
• HDAC6: Ubiquitin-binding that delivers to autophagy
• CHIP: Cochaperone with E3 activity

Research Directions

Key Questions

Emerging Areas

• Single-cell analysis: GID4 expression in specific neuronal populations
• Proteomics: Identification of GID4 substrates in brain
• Structural studies: GID4-substrate interactions

Cross-Links

• [Protein Degradation](/mechanisms/protein-degradation) — UPS pathway
• [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) — Full mechanism
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease context
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease context
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics) — Mitochondrial quality control

References